![Transparency Market Researchが調査・発行した産業分析レポートです。医療大麻の世界市場2019-2027：誘導体別（カンナビジオール[CBD]、テトラヒドロカンナビノール[THC]、その他）、用途別、投与経路別、流通経路別 / Medical Cannabis Market (Derivative: Cannabidiol [CBD], Tetrahydrocannabinol [THC], and Others; Application: Mental Health Management, Neurological Disorders Management, and Pain Management; Route of Administration: Nasal, Oral, and Others; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027 / TMR2006017資料のイメージです。](https://www.marketresearch.co.jp/images-folder2/99x123xreport-contents-78.gif.pagespeed.ic.cYgo-ZH9PJ.jpg) | • レポートコード：TMR2006017 • 出版社/出版日：Transparency Market Research / 2020年3月 • レポート形態：英文、PDF、172ページ • 納品方法：Eメール • 産業分類：医薬品 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、医療大麻の世界市場について、序論、仮定・調査手法、エグゼクティブサマリー、市場動向、キーインサイト、誘導体別（カンナビジオール[CBD]、テトラヒドロカンナビノール[THC]、その他）分析、用途別分析、投与経路別分析、流通経路別分析、地域別（北米、ヨーロッパ、中南米、その他の地域）分析、競争状況などを総合的に調査・分析して掲載しております。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場動向 ・キーインサイト ・医療大麻の世界市場規模：誘導体別（カンナビジオール[CBD]、テトラヒドロカンナビノール[THC]、その他） ・医療大麻の世界市場規模：用途別 ・医療大麻の世界市場規模：投与経路別 ・医療大麻の世界市場規模：流通経路別 ・医療大麻の世界市場規模：地域別（北米、ヨーロッパ、中南米、その他の地域） ・競争状況 |
Medical Cannabis Market – Scope of the Report
TMR’s report on the global medical cannabis market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2019 to 2027. The report provides the revenue of the global medical cannabis market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global medical cannabis market for the forecast period.
The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ literature, annual reports, press releases, and relevant documents to understand the global medical cannabis market. Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have also employed a combination of top-down and bottom-up approaches to study various phenomena in the global medical cannabis market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Additionally, the report sheds light on the changing competitive dynamics in the global medical cannabis market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global medical cannabis market. The next section of the global medical cannabis market report highlights the USPs, which include drivers & restraints impact analysis, value chain analysis, key mergers & acquisitions, top 3 players operating in the medical cannabis market, and qualitative analysis of medical cannabis.
Key Questions Answered in Medical Cannabis Market Report
What will be the sales/revenue generated by different medical cannabis derivatives across all the regions during the forecast period?
What are the major drivers, restraints, and opportunities of the global medical cannabis market?
Which region is set to expand at the fastest CAGR during the forecast period?
Which segment will have the highest revenue globally in 2027 and which derivative segment will expand at the fastest CAGR during the forecast period?
Medical Cannabis Market – Research Objectives and Research Approach
The comprehensive report on the global medical cannabis market begins with an overview of the market, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives of the study and healthcare compliances laid down by accredited agencies in the purview of research in the global medical cannabis market. It is followed by market introduction, market dynamics, and an overview of the global medical cannabis market, which includes TMR analysis of market drivers, restraints, and trends affecting the growth of the global market. Moreover, Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the global medical cannabis market.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into smaller ones. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period. Revenue generated by key medical cannabis agent manufacturers has been mapped to ascertain the size of the global medical cannabis market in terms of revenue. The forecast presented here assesses the total revenue generated by derivatives. In order to provide an accurate forecast, we initiated by sizing up the current medical cannabis market.
The report also delves into the competitive landscape of the global medical cannabis market. Key players operating in the global medical cannabis treatment market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standing, recent developments, and SWOT are some of the attributes of players profiled in the global medical cannabis treatment market report.
レポート目次1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology
3. Executive Summary
3.1. Global Medical Cannabis Market: Market Snapshot
4. Market Overview
4.1. Global Medical Cannabis Market: Type Overview
4.2. Global Medical Cannabis Market: Key Industry Developments
4.3. Market Dynamics
4.4. Drivers and Restraints Snapshot Analysis
4.5. Drivers
4.6. Restraints
4.7. Opportunities
4.8. Global Medical Cannabis Market Revenue Projections (US$ Mn), 2017–2027
5. Key Insights
5.1. Key Mergers & Acquisitions
5.2. Overview of Legal Medical Marijuana in the U.S. States
5.3. Regulatory Scenario Assessment
5.4. Review of Medical Cannabis Clinical Trials
5.5. Top 3 players operating in the market
6. Global Medical Cannabis Market Analysis, by Derivative
6.1. Introduction
6.2. Global Medical Cannabis Market Value and Forecast, by Derivative
6.2.1. Tetrahydrocannabinol (THC)
6.2.2. Cannabidiol (CBD)
6.2.3. Others
6.3. Global Medical Cannabis Market Analysis, by Derivative
6.4. Global Medical Cannabis Market Attractiveness Analysis, by Derivative
7. Global Medical Cannabis Market Analysis, by Application
7.1. Introduction
7.2. Global Medical Cannabis Market Value and Forecast, by Application
7.2.1. Mental Health Management
7.2.1.1. Anxiety
7.2.1.2. Depression
7.2.1.3. Others
7.2.2. Neurological Disorders Management
7.2.2.1. Epilepsy
7.2.2.2. Alzheimer’s Disease
7.2.2.3. Parkinson’s Disease
7.2.2.4. Others
7.2.3. Pain Management
7.2.3.1. Neuropathic Pain
7.2.3.2. Cancer Pain
7.2.3.3. Others
7.3. Global Medical Cannabis Market Analysis, by Application
7.4. Global Medical Cannabis Market Attractiveness Analysis, by Application
8. Global Medical Cannabis Market Analysis, by Route of Administration
8.1. Introduction
8.2. Global Medical Cannabis Market Value and Forecast, by Route of Administration
8.2.1. Nasal
8.2.2. Oral
8.2.3. Others
8.3. Global Medical Cannabis Market Analysis, by Route of Administration
8.4. Global Medical Cannabis Market Attractiveness Analysis, by Route of Administration
9. Global Medical Cannabis Market Analysis, by Distribution Channel
9.1. Introduction
9.2. Global Medical Cannabis Market Value and Forecast, by Distribution Channel
9.2.1. Hospital Pharmacies
9.2.2. Retail Pharmacies
9.2.3. Online Pharmacies
9.3. Global Medical Cannabis Market Analysis, by Distribution Channel
10. Global Medical Cannabis Market Attractiveness Analysis, by Distribution Channel
11. Global Medical Cannabis Market Analysis, by Region
11.1. Global Medical Cannabis Market Value and Forecast, by Region, 2017–2027
11.1.1. North America
11.1.2. Europe
11.1.3. Latin America
11.1.4. Rest of the World
11.2. Global Medical Cannabis Market Analysis, by Region
11.3. Global Medical Cannabis Market Attractiveness Analysis, by Region
12. North America Medical Cannabis Market Analysis
12.1. North America Medical Cannabis Market
12.2. North America Medical Cannabis Market Overview
12.3. North America Medical Cannabis Market Value and Forecast, by Derivative
12.3.1. Tetrahydrocannabinol (THC)
12.3.2. Cannabidiol (CBD)
12.3.3. Others
12.4. North America Medical Cannabis Market Value and Forecast, by Application
12.4.1. Mental Health Management
12.4.1.1. Anxiety
12.4.1.2. Depression
12.4.1.3. Others
12.4.2. Neurological Disorders Management
12.4.2.1. Epilepsy
12.4.2.2. Alzheimer’s Disease
12.4.2.3. Parkinson’s Disease
12.4.2.4. Others
12.4.3. Pain Management
12.4.3.1. Neuropathic Pain
12.4.3.2. Cancer Pain
12.4.3.3. Others
12.5. North America Medical Cannabis Market Value and Forecast, by Route of Administration
12.5.1. Nasal
12.5.2. Oral
12.5.3. Others
12.6. North America Medical Cannabis Market Value and Forecast, by Distribution Channel
12.6.1. Hospital Pharmacies
12.6.2. Retail Pharmacies
12.6.3. Online Pharmacies
12.7. North America Medical Cannabis Market Forecast, by Country
12.7.1. U.S.
12.7.2. Canada
12.8. North America Medical Cannabis Market Attractiveness Analysis
12.8.1. By Derivative
12.8.2. By Application
12.8.3. By Route of Administration
12.8.4. By Distribution Channel
12.8.5. By Country
13. Europe Medical Cannabis Market Analysis
13.1. Europe Medical Cannabis Market
13.2. Europe Medical Cannabis Market Overview
13.3. Europe Medical Cannabis Market Value and Forecast, by Derivative
13.3.1. Tetrahydrocannabinol (THC)
13.3.2. Cannabidiol (CBD)
13.3.3. Others
13.4. Europe Medical Cannabis Market Value and Forecast, by Application
13.4.1. Mental Health Management
13.4.1.1. Anxiety
13.4.1.2. Depression
13.4.1.3. Others
13.4.2. Neurological Disorders Management
13.4.2.1. Epilepsy
13.4.2.2. Alzheimer’s Disease
13.4.2.3. Parkinson’s Disease
13.4.2.4. Others
13.4.3. Pain Management
13.4.3.1. Neuropathic Pain
13.4.3.2. Cancer Pain
13.4.3.3. Others
13.5. Europe Medical Cannabis Market Value and Forecast, by Route of Administration
13.5.1. Nasal
13.5.2. Oral
13.5.3. Others
13.6. Europe Medical Cannabis Market Value and Forecast, by Distribution Channel
13.6.1. Hospital Pharmacies
13.6.2. Retail Pharmacies
13.6.3. Online Pharmacies
13.7. Europe Medical Cannabis Market Forecast, by Country/Sub-region
13.7.1. U.K.
13.7.2. France
13.7.3. Germany
13.7.4. Spain
13.7.5. Italy
13.7.6. Rest of Europe
13.8. Europe Medical Cannabis Market Attractiveness Analysis
13.8.1. By Derivative
13.8.2. By Application
13.8.3. By Route of Administration
13.8.4. By Distribution Channel
13.8.5. By Country/Sub-region
14. Latin America Medical Cannabis Market Analysis
14.1. Latin America Medical Cannabis Market
14.2. Latin America Medical Cannabis Market Overview
14.3. Latin America Medical Cannabis Market Value and Forecast, by Derivative
14.3.1. Tetrahydrocannabinol (THC)
14.3.2. Cannabidiol (CBD)
14.3.3. Others
14.4. Latin America Medical Cannabis Market Value and Forecast, by Application
14.4.1. Mental Health Management
14.4.1.1. Anxiety
14.4.1.2. Depression
14.4.1.3. Others
14.4.2. Neurological Disorders Management
14.4.2.1. Epilepsy
14.4.2.2. Alzheimer’s Disease
14.4.2.3. Parkinson’s Disease
14.4.2.4. Others
14.4.3. Pain Management
14.4.3.1. Neuropathic Pain
14.4.3.2. Cancer Pain
14.4.3.3. Others
14.5. Latin America Medical Cannabis Market Value and Forecast, by Route of Administration
14.5.1. Nasal
14.5.2. Oral
14.5.3. Others
14.6. Latin America Medical Cannabis Market Value and Forecast, by Distribution Channel
14.6.1. Hospital Pharmacies
14.6.2. Retail Pharmacies
14.6.3. Online Pharmacies
14.7. Latin America Medical Cannabis Market Forecast, by Country/Sub-region
14.7.1. Brazil
14.7.2. Mexico
14.7.3. Rest of Latin America
14.8. Latin America Medical Cannabis Market Attractiveness Analysis
14.8.1. By Derivative
14.8.2. By Application
14.8.3. By Route of Administration
14.8.4. By Distribution Channel
14.8.5. By Country/Sub-region
15. Rest of the World Medical Cannabis Market Analysis
15.1. Rest of the World Medical Cannabis Market
15.2. Rest of the World Medical Cannabis Market Overview
15.3. Rest of the World Medical Cannabis Market Value and Forecast, by Derivative
15.3.1. Tetrahydrocannabinol (THC)
15.3.2. Cannabidiol (CBD)
15.3.3. Others
15.4. Rest of the World Medical Cannabis Market Value and Forecast, by Application
15.4.1. Mental Health Management
15.4.1.1. Anxiety
15.4.1.2. Depression
15.4.1.3. Others
15.4.2. Neurological Disorders Management
15.4.2.1. Epilepsy
15.4.2.2. Alzheimer’s Disease
15.4.2.3. Parkinson’s Disease
15.4.2.4. Others
15.4.3. Pain Management
15.4.3.1. Neuropathic Pain
15.4.3.2. Cancer Pain
15.4.3.3. Others
15.5. Rest of the World Medical Cannabis Market Value and Forecast, by Route of Administration
15.5.1. Nasal
15.5.2. Oral
15.5.3. Others
15.6. Rest of the World Medical Cannabis Market Value and Forecast, by Distribution Channel
15.6.1. Hospital Pharmacies
15.6.2. Retail Pharmacies
15.6.3. Online Pharmacies
15.7. Rest of the World Medical Cannabis Market Attractiveness Analysis
15.7.1. By Derivative
15.7.2. By Application
15.7.3. By Route of Administration
15.7.4. By Distribution Channel
16. Competitive Landscape
16.1. Company Profiles
16.1.1. Canopy Growth Corporation
16.1.1.1. Overview (HQ, Employee Strength, Business Segments)
16.1.1.2. Financials
16.1.1.3. Recent Developments
16.1.1.4. Strategy
16.1.2. United Cannabis
16.1.2.1. Overview (HQ, Employee Strength, Business Segments)
16.1.2.2. Financials
16.1.2.3. Recent Developments
16.1.2.4. Strategy
16.1.3. Aurora Cannabis
16.1.3.1. Overview (HQ, Employee Strength, Business Segments)
16.1.3.2. Financials
16.1.3.3. Recent Developments
16.1.3.4. Strategy
16.1.4. Cannabis Sativa, Inc.
16.1.4.1. Overview (HQ, Employee Strength, Business Segments)
16.1.4.2. Financials
16.1.4.3. Recent Developments
16.1.4.4. Strategy
16.1.5. Emerald Health Therapeutics
16.1.5.1. Overview (HQ, Employee Strength, Business Segments)
16.1.5.2. Financials
16.1.5.3. Recent Developments
16.1.5.4. Strategy
16.1.6. GW Pharmaceuticals plc.
16.1.6.1. Overview (HQ, Employee Strength, Business Segments)
16.1.6.2. Recent Developments
16.1.6.3. Strategy
16.1.7. Tilray
16.1.7.1. Overview (HQ, Employee Strength, Business Segments)
16.1.7.2. Recent Developments
16.1.7.3. Strategy
16.1.8. Medical Marijuana, Inc.
16.1.8.1. Overview (HQ, Employee Strength, Business Segments)
16.1.8.2. Financials
16.1.8.3. Recent Developments
16.1.8.4. Strategy
16.1.9. The Cronos Group.
16.1.9.1. Overview (HQ, Employee Strength, Business Segments)
16.1.9.2. Financials
16.1.9.3. Recent Developments
16.1.9.4. Strategy
16.1.10. The Supreme Cannabis Company, Inc.
16.1.10.1. Overview (HQ, Employee Strength, Business Segments)
16.1.10.2. Recent Developments
16.1.10.3. Strategy
List of TablesTABLE 1 Global Medical Cannabis Market Value (US$ Mn) Forecast, by Derivative, 2017–2027
TABLE 2 Global Medical Cannabis Market Value (US$ Mn) Forecast, by Application, 2017–2027
TABLE 3 Global Medical Cannabis Market Value (US$ Mn) Forecast, by Mental Health Management, 2017–2027
TABLE 4 Global Medical Cannabis Market Value (US$ Mn) Forecast, by Neurological Disorders Management, 2017–2027
TABLE 5 Global Medical Cannabis Market Value (US$ Mn) Forecast, by Pain Management, 2017–2027
TABLE 6 Global Medical Cannabis Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027
TABLE 7 Global Medical Cannabis Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
TABLE 8 Global Medical Cannabis Market Value (US$ Mn) Forecast, by Region, 2017–2027
TABLE 9 North America Medical Cannabis Market Value (US$ Mn) Forecast, by Country, 2017–2027
TABLE 10 North America Medical Cannabis Market Value (US$ Mn) Forecast, by Derivative, 2017–2027
TABLE 11 North America Medical Cannabis Market Value (US$ Mn) Forecast, by Application, 2017–2027
TABLE 12 North America Medical Cannabis Market Value (US$ Mn) Forecast, by Mental Health Management, 2017–2027
TABLE 13 North America Medical Cannabis Market Value (US$ Mn) Forecast, by Neurological Disorders Management, 2017–2027
TABLE 14 North America Medical Cannabis Market Value (US$ Mn) Forecast, by Pain Management, 2017–2027
TABLE 15 North America Medical Cannabis Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027
TABLE 16 North America Medical Cannabis Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
TABLE 17 Europe Medical Cannabis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
TABLE 18 Europe Medical Cannabis Market Value (US$ Mn) Forecast, by Derivative, 2017–2027
TABLE 19 Europe Medical Cannabis Market Value (US$ Mn) Forecast, by Application, 2017–2027
TABLE 20 Europe Medical Cannabis Market Value (US$ Mn) Forecast, by Mental Health Management, 2017–2027
TABLE 21 Europe Medical Cannabis Market Value (US$ Mn) Forecast, by Neurological Disorders Management, 2017–2027
TABLE 22 Europe Medical Cannabis Market Value (US$ Mn) Forecast, by Pain Management, 2017–2027
TABLE 23 Europe Medical Cannabis Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027
TABLE 24 Europe Medical Cannabis Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
TABLE 25 Latin America Medical Cannabis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
TABLE 26 Latin America Medical Cannabis Market Value (US$ Mn) Forecast, by Derivative, 2017–2027
TABLE 27 Latin America Medical Cannabis Market Value (US$ Mn) Forecast, by Application, 2017–2027
TABLE 28 Latin America Medical Cannabis Market Value (US$ Mn) Forecast, by Mental Health Management, 2017–2027
TABLE 29 Latin America Medical Cannabis Market Value (US$ Mn) Forecast, by Neurological Disorders Management, 2017–2027
TABLE 30 Latin America Medical Cannabis Market Value (US$ Mn) Forecast, by Pain Management, 2017–2027
TABLE 31 Latin America Medical Cannabis Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027
TABLE 32 Latin America Medical Cannabis Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027
TABLE 33 Rest of the World Medical Cannabis Market Value (US$ Mn) Forecast, by Derivative, 2017–2027
TABLE 34 Rest of the World Medical Cannabis Market Value (US$ Mn) Forecast, by Application, 2017–2027
TABLE 35 Rest of the World Medical Cannabis Market Value (US$ Mn) Forecast, by Mental Health Management, 2017–2027
TABLE 36 Rest of the World Medical Cannabis Market Value (US$ Mn) Forecast, by Neurological Disorders Management, 2017–2027
TABLE 37 Rest of the World Medical Cannabis Market Value (US$ Mn) Forecast, by Pain Management, 2017–2027
TABLE 38 Rest of the World Medical Cannabis Market Value (US$ Mn) Forecast, by Route of Administration, 2017–2027
TABLE 39 Rest of the World Medical Cannabis Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027